LIGHT (lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpes virus entry mediator on T cells, also known as TNFSF14) has been identified as a pathogenic threat in various inflammatory diseases such as asthma (2). Here, TNFSF14 is linked to asthma.